Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
6.39
+0.04 (0.63%)
At close: Dec 5, 2025, 4:00 PM EST
6.27
-0.12 (-1.88%)
After-hours: Dec 5, 2025, 5:58 PM EST
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $207.81 million as of December 5, 2025. Its market cap has increased by 46.37% in one year.
Market Cap
207.81M
Enterprise Value
82.43M
1-Year Change
46.37%
Ranking
Category
Stock Price
$6.39
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $207.81M, a decrease of -41.43%. That is a compound annual growth rate of -20.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 207.81M | 43.44% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |